Texas Instruments Incorporated
NASDAQ:TXNSemiconductors
+$19.10 today
- Market cap
- $270.35B
- Beta
- 1.31
- P/E (TTM)
- 54.4
- EPS (TTM)
- $5.90
- Dividend yield
- 1.75%
Volume 5.80M
Average 7.78M
TXN Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Texas Instruments IncorporatedNASDAQ: TXN
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development grows in line with its trailing trend
Q3 FY2026 research & development of $530M rose 2.3% year over year, in line with the +2.1% change in trailing-twelve-month research & development. Sequentially, it fell 0.9% from the prior quarter. Over 3 fiscal years it compounded at +7.6% a year.
Context
- Research & development amounted to 11.8% of revenue in FY2025, down 0.7 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +2.3% holds above the trailing-twelve-month pace of +2.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 2.08B USD
- Year-over-year change
- +6.3%
- 4-year CAGR
- +7.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.08B | +6.3% |
| FY2024 | 2024-12-31 | 1.96B | +5.2% |
| FY2023 | 2023-12-31 | 1.86B | +11.6% |
| FY2022 | 2022-12-31 | 1.67B | +7.5% |
| FY2021 | 2021-12-31 | 1.55B | — |
Research & Development vs competitors
How TXN compares with its peers on the latest reported figures
- TXN's LTM Sep 2026 research & development of $2.1B is the 2nd highest of the 11 companies compared; the peer median is $429.51M.
- Its year-over-year change of +2.1% is the 8th highest of 11, against a peer median of +4.9%.
- Research & development amounts to 10.1% of revenue for TXN, versus a peer median of 16.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.43B | +5.3% | +3.2% | 18.4% | |
| LTM Sep 2026 | $2.1B | +2.1% | +7.6% | 10.1% | |
| LTM Aug 2026 | $1.98B | +17.8% | +1.3% | 14.2% | |
| LTM Jun 2026 | $1.14B | +14.2% | -1.0% | 22.2% | |
| LTM Oct 2026 | $563.9M | -6.8% | -0.9% | 8.9% | |
| LTM Jun 2026 | $446.07M | +3.2% | -1.8% | 21.8% | |
| LTM Jun 2026 | $412.95M | +14.9% | +16.8% | 12.6% | |
| LTM Jun 2026 | $164.12M | +4.5% | -2.8% | 19.9% | |
| LTM Sep 2026 | $102.84M | +0.4% | +2.5% | 22.6% | |
| LTM Mar 2026 | $99.82M | +8.9% | +9.8% | 14.6% | |
| LTM Oct 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding TXN) | $429.51M | +4.9% | +1.3% | 16.5% | |
Competitors are the stored peer set for TXN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 18.34B | 20.03B | 17.52B | 15.64B | 17.68B |
| Cost of Revenue | 5.97B | 6.26B | 6.5B | 6.55B | 7.6B |
| Gross Profit | 12.38B | 13.77B | 11.02B | 9.09B | 10.08B |
| Gross Margin | 67.5% | 68.8% | 62.9% | 58.1% | 57.0% |
| Research & Development | 1.55B | 1.67B | 1.86B | 1.96B | 2.08B |
| Selling, General & Admin | 1.67B | 1.7B | 1.83B | 1.79B | 1.86B |
| Operating Expenses | 3.42B | 3.63B | 3.69B | 3.63B | 4.06B |
| Depreciation & Amortization | 954M | 979M | 1.24B | 1.58B | 2B |
| EBITDA | 10.06B | 11.23B | 9.01B | 7.54B | 8.25B |
| EBITDA Margin | 54.8% | 56.0% | 51.4% | 48.2% | 46.7% |
| Operating Income | 8.96B | 10.14B | 7.33B | 5.47B | 6.02B |
| Operating Margin | 48.8% | 50.6% | 41.8% | 34.9% | 34.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 184M | 214M | 353M | 508M | 543M |
| Other Income / Expenses | (41M) | (108M) | 87M | (12M) | (313M) |
| Income Before Tax | 8.92B | 10.03B | 7.42B | 5.45B | 5.71B |
| Pre-Tax Margin | 48.6% | 50.1% | 42.3% | 34.9% | 32.3% |
| Income Tax Expense | 1.15B | 1.28B | 908M | 654M | 709M |
| Net Income | 7.77B | 8.75B | 6.51B | 4.8B | 5B |
| Net Margin | 42.4% | 43.7% | 37.2% | 30.7% | 28.3% |
| EPS (Basic) | 8.38 | 9.51 | 7.13 | 5.24 | 5.45 |
| EPS (Diluted) | 8.27 | 9.41 | 7.07 | 5.20 | 5.45 |
| Weighted Avg Shares | 923M | 916M | 908M | 912M | 909M |
| Weighted Avg Shares (Diluted) | 936M | 926M | 916M | 919M | 913M |
Texas Instruments Incorporated
NASDAQ:TXN
Intrinsic Alpha fair value
Locked
Current Price
$295.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.